Indonesia · Delayed Price · Currency is IDR PT Medikaloka Hermina Tbk Statistics
Total Valuation
IDX:HEAL has a market cap or net worth of IDR 24.64 trillion. The enterprise value is 28.38 trillion.
| Market Cap | 24.64T |
| Enterprise Value | 28.38T |
Important Dates
The last earnings date was Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | May 5, 2025 |
Share Statistics
IDX:HEAL has 14.89 billion shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 14.89B |
| Shares Outstanding | 14.89B |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +3.19% |
| Owned by Insiders (%) | 39.90% |
| Owned by Institutions (%) | 8.17% |
| Float | 7.84B |
Valuation Ratios
The trailing PE ratio is 58.99 and the forward PE ratio is 40.05. IDX:HEAL's PEG ratio is 2.82.
| PE Ratio | 58.99 |
| Forward PE | 40.05 |
| PS Ratio | 3.64 |
| PB Ratio | 3.51 |
| P/TBV Ratio | 4.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 23.37 |
| PEG Ratio | 2.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.46, with an EV/FCF ratio of -30.15.
| EV / Earnings | 67.95 |
| EV / Sales | 4.20 |
| EV / EBITDA | 16.46 |
| EV / EBIT | 30.94 |
| EV / FCF | -30.15 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.76 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | -3.83 |
| Interest Coverage | 4.03 |
Financial Efficiency
Return on equity (ROE) is 8.39% and return on invested capital (ROIC) is 5.97%.
| Return on Equity (ROE) | 8.39% |
| Return on Assets (ROA) | 5.26% |
| Return on Invested Capital (ROIC) | 5.97% |
| Return on Capital Employed (ROCE) | 8.92% |
| Revenue Per Employee | 370.25M |
| Profits Per Employee | 22.87M |
| Employee Count | 17,626 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 38.91 |
Taxes
In the past 12 months, IDX:HEAL has paid 185.87 billion in taxes.
| Income Tax | 185.87B |
| Effective Tax Rate | 25.91% |
Stock Price Statistics
The stock price has increased by +27.65% in the last 52 weeks. The beta is 0.19, so IDX:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +27.65% |
| 50-Day Moving Average | 1,493.20 |
| 200-Day Moving Average | 1,403.30 |
| Relative Strength Index (RSI) | 62.77 |
| Average Volume (20 Days) | 22,782,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:HEAL had revenue of IDR 6.76 trillion and earned 417.63 billion in profits. Earnings per share was 28.06.
| Revenue | 6.76T |
| Gross Profit | 2.19T |
| Operating Income | 917.30B |
| Pretax Income | 717.45B |
| Net Income | 417.63B |
| EBITDA | 1.72T |
| EBIT | 917.30B |
| Earnings Per Share (EPS) | 28.06 |
Balance Sheet
The company has 1.42 trillion in cash and 3.61 trillion in debt, giving a net cash position of -2,194.34 billion or -147.37 per share.
| Cash & Cash Equivalents | 1.42T |
| Total Debt | 3.61T |
| Net Cash | -2,194.34B |
| Net Cash Per Share | -147.37 |
| Equity (Book Value) | 7.01T |
| Book Value Per Share | 356.18 |
| Working Capital | 1.25T |
Cash Flow
In the last 12 months, operating cash flow was 1.05 trillion and capital expenditures -1,995.65 billion, giving a free cash flow of -941.27 billion.
| Operating Cash Flow | 1.05T |
| Capital Expenditures | -1,995.65B |
| Free Cash Flow | -941.27B |
| FCF Per Share | -63.21 |
Margins
Gross margin is 32.38%, with operating and profit margins of 13.57% and 6.18%.
| Gross Margin | 32.38% |
| Operating Margin | 13.57% |
| Pretax Margin | 10.61% |
| Profit Margin | 6.18% |
| EBITDA Margin | 25.43% |
| EBIT Margin | 13.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 0.63%.
| Dividend Per Share | 10.50 |
| Dividend Yield | 0.63% |
| Dividend Growth (YoY) | 23.53% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 37.23% |
| Buyback Yield | -1.53% |
| Shareholder Yield | -0.90% |
| Earnings Yield | 1.69% |
| FCF Yield | -3.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 30, 2021. It was a forward split with a ratio of 5.
| Last Split Date | Jul 30, 2021 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |